Latest news
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder - Medical DailyMedical Daily · Fri, 07 Aug 2026 10:30:02 GMTNew Narcolepsy Drug Signals a Shift From Symptom Management to Disease-Based Treatment - inklinkl · Fri, 07 Aug 2026 08:26:44 GMTFDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 - Patient Care OnlinePatient Care Online · Fri, 07 Aug 2026 06:16:23 GMTFDA Approves First-in-Class Narcolepsy Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 20:46:04 GMTFDA Approves Orezeyful for Narcolepsy Type 1 in Adults - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 15:12:46 GMTTakeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:10:41 GMTTakeda’s narcolepsy nod opens orexin doors - BioSpaceBioSpace · Thu, 06 Aug 2026 13:17:40 GMT